Fujifilm has developed a new “pain-free” alternative to hypodermic needles which delivers drugs through a sheet of material covered in tiny dissolvable needles.
The US FDA has finally adopted the revised ICH Q11 guidelines on drug substance manufacturing nearly six months after European regulators embraced the guidelines.
Marinomed Biotechnologies is set to take on the ‘common cold’ in China with a new patent for an anti-viral polymer technology that prevents rhinovirus infection.
in-PharmaTechnologist.com presents its weekly round-up of the latest new appoitnments within the world of pharma and biopharma including news from J&J, Teva and Amarantus.
All parties involved in the distribution of biologics in India must take responsibility for quality and keep seasonal temperature variations in mind says the CDSCO.
Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT).
Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.
Manufacturers trying to prove the similarity of their biosimilars must consider that regulations and reference medicines differ in different markets says Pfizer.
Outsourcing-Pharma.com presents its weekly round-up of the latest appointments in the pharma services industry, including news from Chiltern, Novacep and Emergent.
Thermo Fisher Scientific has set up a unit for molecular biology techs at its site in Lithuania, citing pharmaceutical R&D labs in Eastern Europe as a target.
Agricultural technology firm Monsanto has partnered with Complix NV to develop the latter’s protein therapeutic targeting technology for crop protection applications.
